Bloomberg Becomes WHO Global Ambassador for Noncommunicable Diseases

NCDs include heart disease, stroke, cancer, diabetes, and chronic respiratory diseases. Together with injuries, they are responsible for 43 million deaths each year, or almost 80 percent of all deaths worldwide.

The World Health Organization named Michael Bloomberg, who served three terms as mayor of the New York City, as Global Ambassador for Noncommunicable Diseases on Aug. 17. Bloomberg has been working with WHO on tobacco control and injury prevention for the past decade.

"Michael Bloomberg is a valued partner and has a long track record of supporting WHO in the areas of tobacco control, improving data for health, road safety, and drowning prevention," said Dr. Margaret Chan, WHO's director-general. "I am therefore absolutely delighted to be able to appoint him as Global Ambassador for Noncommunicable Diseases. This will enable us to strengthen our response together to the major public health challenges of NCDs and injuries."

NCDs include heart disease, stroke, cancer, diabetes, and chronic respiratory diseases. Together with injuries, they are responsible for 43 million deaths each year, or almost 80 percent of all deaths worldwide. Each year, 16 million people die from NCDs before the age of 70, with road traffic crashes accounting for a further 1.25 million deaths each year and being the leading cause of death among young people ages 15-29.

Bloomberg will work with national and local political leaders worldwide on strategies to reduce the burden of NCDs and injuries and will help WHO in supporting the attainment of the United Nations' Sustainable Development Goals. "I am honored to become WHO Global Ambassador for Noncommunicable Diseases and excited about the possibilities that are within our reach. Cities and countries around the world are making great progress reducing preventable, premature deaths and, by replicating the most effective measures on a global scale, we can save many millions of lives," he said. "Together with WHO, we'll support low- and middle-income countries as they work to achieve their policy goals and direct resources in ways that will best improve public health. We'll also work to raise awareness among leaders and policy makers at the local level about the real gains that can be achieved when effective programs are in place."

Product Showcase

  • SwabTek® Cannabis Test Kit

    The SwabTek® Cannabis Test Kit is a single-use spot test designed for use in screening for cannabis compounds in any sample type or on any surface. The test is capable of identifying the presumed presence of cannabinoids in very small quantities, with a level of detection as little as 6 μg in mass. Learn more about the SwabTek® Cannabis Test Kit and the rest of SwabTek surface drug testing solutions through the webinar titled "Everything You Want To Know About Surface Testing" Read More

  • Safety Shower Test Cart

    The Safety Shower Test Cart speeds up and simplifies emergency shower tests, ensures you stay in compliance with OSHA regulations, and significantly reduces testing costs. With 7 unique features, the cart makes testing easy, effective, and efficient. You can test water clarity, flow, temperature, and spread—all at the same time! Most safety shower testing kits create a mess, take too much time to use, and don't fully help you stay in compliance with OSHA & ANSI standards. Transform the way you test emergency showers with Green Gobbler Safety. Read More

  • Magid® D-ROC® GPD412 21G Ultra-Thin Polyurethane Palm Coated Work Gloves

    Magid’s 21G line is more than just a 21-gauge glove, it’s a revolutionary knitting technology paired with an advanced selection of innovative fibers to create the ultimate in lightweight cut protection. The latest offering in our 21G line provides ANSI A4 cut resistance with unparalleled dexterity and extreme comfort that no other 21-gauge glove on the market can offer! Read More

Featured

Artificial Intelligence

Webinars